Abstract
The aim of this work was to investigate the antibacterial activity of clove (Syzygium aromaticum) essential oil against multidrug resistant clinical strains of Klebsiella pneumoniae ESBL+. Materials: The antibacterial activity of the oil was tested against standard strain Klebsiella pneumoniae ATCC 700603 and 60 clinical strains of Klebsiella pneumoniae isolated from patients with infections of the respiratory tract, abdominal cavity, urinary tract, skin and from the hospital environment. Methods: The agar dilution method was used to assess the inhibition of microbial growth at various concentrations of the clove oil. Susceptibility testing to antibiotics was carried out using disc-diffusion. Results: The results of experiments showed that clove essential oil possessed very strong activity against all of the clinical strains of extendedspectrum β-lactamase (ESBL)-producing ESBL+ from Klebsiella pneumoniae. Conclusions: The results of this study suggest the potential use of clove essential oil against K. pneumoniae ESBL+ that is responsible for infections difficult to treat. Essential oils my be an excellent alternative for synthetic preparations and, used in combination with antibiotics, may prevent antibiotic-resistant strain development.
Keywords: Clove essential oil, ESBL+, K. pneumoniae, Minimal Inhibitory Concentration.
Anti-Infective Agents
Title:The Susceptibility of Klebsiella pneumoniae ESBL+ Strains to Clove (Syzygium aromaticum) Essential Oil
Volume: 11 Issue: 2
Author(s): Monika Sienkiewicz, Danuta Kalemba and Malgorzata Wasiela
Affiliation:
Keywords: Clove essential oil, ESBL+, K. pneumoniae, Minimal Inhibitory Concentration.
Abstract: The aim of this work was to investigate the antibacterial activity of clove (Syzygium aromaticum) essential oil against multidrug resistant clinical strains of Klebsiella pneumoniae ESBL+. Materials: The antibacterial activity of the oil was tested against standard strain Klebsiella pneumoniae ATCC 700603 and 60 clinical strains of Klebsiella pneumoniae isolated from patients with infections of the respiratory tract, abdominal cavity, urinary tract, skin and from the hospital environment. Methods: The agar dilution method was used to assess the inhibition of microbial growth at various concentrations of the clove oil. Susceptibility testing to antibiotics was carried out using disc-diffusion. Results: The results of experiments showed that clove essential oil possessed very strong activity against all of the clinical strains of extendedspectrum β-lactamase (ESBL)-producing ESBL+ from Klebsiella pneumoniae. Conclusions: The results of this study suggest the potential use of clove essential oil against K. pneumoniae ESBL+ that is responsible for infections difficult to treat. Essential oils my be an excellent alternative for synthetic preparations and, used in combination with antibiotics, may prevent antibiotic-resistant strain development.
Export Options
About this article
Cite this article as:
Sienkiewicz Monika, Kalemba Danuta and Wasiela Malgorzata, The Susceptibility of Klebsiella pneumoniae ESBL+ Strains to Clove (Syzygium aromaticum) Essential Oil, Anti-Infective Agents 2013; 11 (2) . https://dx.doi.org/10.2174/2211352511311020010
DOI https://dx.doi.org/10.2174/2211352511311020010 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Wound Healing Effects of Curcumin: A Short Review
Current Pharmaceutical Biotechnology Post-Wortmannin Era: Novel Phosphoinositide 3-Kinase Inhibitors with Potential Therapeutic Applications
Current Enzyme Inhibition Central G-Protein Coupled Receptors (GPCR)s as Molecular Targets for the Treatment of Obesity: Assets, Liabilities and Development Status
Current Drug Targets - CNS & Neurological Disorders Editorial (Thematic Issue: Therapies Targeting Oxidative Stress for Human Diseases: Where Are We Now?)
Current Pharmaceutical Biotechnology Type 2 Transglutaminase in Neurodegenerative Diseases: The Mitochondrial Connection
Current Pharmaceutical Design Hematopoietic Stem Cells: Transcriptional Regulation, Ex Vivo Expansion and Clinical Application
Current Molecular Medicine Profiling the Shear Stress of Atherosclerosis; A Genomic View
Current Genomics Peptide Nucleic Acid Conjugates: Synthesis, Properties and Applications
Current Topics in Medicinal Chemistry A Role for Tumor Suppressor Protein p53 in the Fidelity of DNA Synthesis and Resistance Towards Nucleoside Analogs
Current Cancer Therapy Reviews Intercalative Binding of Small Molecules to Nucleic Acids
Current Organic Chemistry Frailty of Older Age: The Role of the Endocrine - Immune Interaction
Current Pharmaceutical Design Utility and Limitations of SP600125, an Inhibitor of Stress-Responsive c-Jun N-Terminal Kinase
Current Enzyme Inhibition Generation, Subsets and Functions of Inducible Regulatory T Cells
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Involvement of Regulatory T Cells in HIV Immunopathogenesis
Current HIV Research Gold(III) Complexes in the Oncological Preclinical Arena: From Aminoderivatives to Peptidomimetics
Current Topics in Medicinal Chemistry Selective Modulation of Aβ42 Production in Alzheimers Disease: Non-Steroidal Anti-Inflammatory Drugs and Beyond
Current Pharmaceutical Design Human Copper Chaperone Atox1 Translocates to the Nucleus but does not Bind DNA In Vitro
Protein & Peptide Letters Suicide Gene Therapy Against Malignant Gliomas by the Local Delivery of Genetically Engineered Umbilical Cord Mesenchymal Stem Cells as Cellular Vehicles
Current Gene Therapy Strategy for a Genetic Assessment of Antipsychotic and Antidepressant- Related Proarrhythmia
Current Medicinal Chemistry Novel Compounds from Marine Microorganisms that Inhibit Mammalian DNA Polymerase
Current Organic Chemistry